Breaking News

Black cancer patients say they aren't offered chance at clinical trials; a make-or-break drug study fails

     

 

Pharmalot Ed Silverman

Many Black cancer patients say they aren't offered the chance at clinical trials, survey finds

By Angus Chen

Angus Chen/STAT

Researchers said the results should force clinicians to see the racial biases that health care has both on a structural and a personal level.

Read More

STAT+: Praxis' novel antidepressant fails make-or-break trial

By Damian Garde

Adobe

The failure of the Praxis trial casts doubt on what was meant to be a nuanced approach to the brain’s natural regulatory system.

Read More

STAT+: Promising results reported for new generation of CAR-T immunotherapy for myeloma

By Angus Chen

New targets, faster manufacturing times, and dual strategies against a cancer that does not currently have a cure.

Read More

Opinion: 'Pink tape' at the FDA is delaying access to contraception — again

By Dana Singiser

Adobe

The FDA's foot dragging on approving over-the-counter oral contraception harkens back to its delays in approving Plan B.

Read More

STAT+: Adicet 'gamma-delta' T cell therapy shows complete remissions in early study of lymphoma patients

By Adam Feuerstein

Courtesy ASCO/Scott Morgan

The off-the-shelf therapy made from a special type of T cell induced complete remissions in patients with advanced B-cell lymphomas.

Read More

Monday, June 6, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments